Diseased Joint Articles & Analysis
17 news found
Dedicated to the research of new immunotherapeutic vaccines in oncology and prophylactic vaccines for contagious diseases, the aim of the joint Institut Pasteur – Oncovita laboratory is to design and develop vaccine candidates through to proof of concept in humans. ...
ByOncoVITA
The CUVIS-Joint robotic platform is currently being used by surgeons in Korea and India with great success. ...
The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent ...
The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent ...
Glucosamine is a natural sugar found in the fluid around joints, animal bones, bone marrow, shellfish and fungi. The glucosamine in supplements usually comes from shellfish, but there are also synthetic forms.Does Glucosamine Cause Liver ...
.*, of INOV8 Surgical, a leading ambulatory surgical center (ASC) in Houston specializing in outpatient total joint procedures, is approaching a key milestone with THINK’s active robot technology. ...
The core technology of the TSolution One has been used in thousands of successful total joint replacements worldwide. THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent ...
“Given his track record of success over decades with Stryker Corporation, including his time as president of the Joint Replacement Division and his experience with Mako robotic-arm technology, Stuart Simpson is uniquely qualified to lead THINK. ...
” About Hyalex Orthopaedics Hyalex is a privately-held medical device company headquartered in Lexington, MA, developing transformational synthetic cartilage technology and implant systems for diseased and damaged joints. HYALEX® Cartilage is protected by more than 17 patents and trademarks worldwide. ...
In sports alone, knee injuries account for 41% of all injuries, and rapidly increasing in prevalence is knee osteoarthritis, a disabling joint disease. The KneeKGTM goes beyond the current standard of care by providing clinicians with real-time, quantifiable data that objectively and accurately assess dynamic knee function to prevent or rehab knee pain and ...
ByEmovi
Innovation Center project of Merck collaborates to develop smart neuro-modulation for targeted treatment of chronic diseases. Joint development agreement represents a promising step towards a highly selective and efficient next generation of bioelectronic therapies powered by graphene. ...
” “The HYALEX Cartilage System is exciting because its biomimetic material properties create the potential to replace a damaged joint surface, and thereby interrupt the progression of cartilage degeneration,” said Dr. ...
About Osteoarthritis Osteoarthritis is the most common chronic degenerative joint disease, characterized by progressive wear of joint cartilage. Clinical manifestations of OA in the knee include, but are not limited to, pain in and around the joint and limited joint motion. Due to the inability of ...
OA is a painful, chronic and progressive joint disease that affects more than 100 million people globally. Symptomatic OA afflicts more than 30 million Americans, and loss of joint function as a result of this condition is a major cause of work disability and reduced quality of life. ...
Fighting the COVID-19 (Corona Virus Disease) epidemic requires joint efforts! GSN Property Services, the leading German property management provider in China, is using bluebee® to monitor progress of disinfection work. ...
Orthocell Ltd (ASX: OCC) is today celebrating the lifelong achievements of Professor Lars Lidgren, a Swedish surgeon, researcher, entrepreneur and Orthocell board member, who has been awarded an honorary fellowship by the American College of Surgeons (ACS). Orthocell Managing Director, Paul Anderson, said the fellowship recognises significant milestones in Professor Lidgren’s career, ...
This new distribution arrangement will get 14-3-3η testing into the hands of more investigators worldwide, including key opinion leaders and pharmaceutical companies, to advance and grow the body of data for this novel joint damage biomarker in autoimmune diseases. There is increasing international momentum to investigate the role of 14-3-3η in various ...